
PPMD created and submitted the “Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment over the Spectrum of Disease” which acted as a pillar in the creation and publication of the FDA Duchenne Guidance, the first guidance drafted by the patient community.